Pegylated liposomal doxorubicin plus highly active antiretroviral therapy versus highly active antiretroviral therapy alone in HIV patients with Kaposi's sarcoma

被引：71
作者：
Martín-Carbonero, L
Barrios, A
Saballs, P
Sirera, G
Santos, J
Palacios, R
Valencia, ME
Alegre, M
Podzamczer, D
González-Lahoz, J
机构：
[1] Hosp Carlos III, Inst Salud Carlos III, Madrid, Spain
[2] Hosp del Mar, Barcelona, Spain
[3] Hosp Badalona Germans Trias & Pujol, Barcelona, Spain
[4] Hosp Univ Virgen Victoria, Malaga, Spain
[5] Hosp Sant Pau, Barcelona, Spain
[6] Hosp Univ Bellvitge, Barcelona, Spain
来源：
AIDS | 2004年 / 18卷 / 12期
关键词：
D O I：
10.1097/01.aids.0000131385.60974.b9
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Twenty-eight HIV patients either naive or failing highly active antiretroviral therapy (HAART) with moderate-advanced Kaposi's sarcoma (KS) were randomly chosen to initiate a new HAART regimen plus pegylated liposomal doxorubicin (PLD) or the new HAART regimen alone. After 48 weeks, better response rates were observed in the HAART plus PLD group (76% versus 20%). In HIV-infected patients with moderate-advanced KS, HAART alone may not be enough for KS response.
引用
收藏
页码：1737 / 1740
页数：4
相关论文
共 50 条
[41]   PARKINSONISM IN HIV-INFECTED PATIENTS ON HIGHLY ACTIVE ANTIRETROVIRAL THERAPY [J].
Tisch, Stephen ;
Brew, Bruce .
NEUROLOGY, 2009, 73 (05) :401-403
[42]   Knee osteonecrosis in HIV patients exposured to highly active antiretroviral therapy [J].
Veyrac, G. ;
Dixneuf, V. ;
Jolliet, P. .
FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2011, 25 :12-12
[43]   Effect of highly active antiretroviral therapy on thrombocytopenia in patients with HIV infection [J].
Caso, JAA ;
Mingo, CS ;
Tena, JG .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (16) :1239-1240
[44]   The effectiveness of highly active antiretroviral therapy in HIV-infected patients [J].
Jensen-Fangel, S .
DANISH MEDICAL BULLETIN, 2004, 51 (04) :371-392
[45]   Parkinsonism in HIV-infected patients on highly active antiretroviral therapy [J].
Tisch, S. ;
Brew, B. J. .
MOVEMENT DISORDERS, 2009, 24 :S425-S425
[46]   Persistent Kaposi sarcoma in the era of highly active antiretroviral therapy: characterizing the predictors of clinical response [J].
Nguyen, Huong Q. ;
Magaret, Amalia S. ;
Kitahata, Mari M. ;
Van Rompaey, Stephen E. ;
Wald, Anna ;
Casper, Corey .
AIDS, 2008, 22 (08) :937-945
[47]   Adherence to highly active antiretroviral therapy [J].
Williams, AB .
NURSING CLINICS OF NORTH AMERICA, 1999, 34 (01) :113-+
[48]   Kaposi's sarcoma in pregnancy after initiation of highly active antiretroviral therapy: a manifestation of immune reconstitution syndrome [J].
Adeyemo, A. ;
Wood, C. ;
Govind, A. .
INTERNATIONAL JOURNAL OF STD & AIDS, 2012, 23 (12) :905-906
[49]   Complete regression of AIDS-related Kaposi's sarcoma in a child treated with highly active antiretroviral therapy [J].
Niehues, T ;
Horneff, G ;
Megahed, M ;
Schroten, H ;
Wahn, V .
AIDS, 1999, 13 (09) :1148-1149
[50]   Progressive Pulmonary Kaposi's Sarcoma in the Setting of Highly Active Antiretroviral Therapy (HAART) Compliance: A Case Report [J].
Hom, K. ;
Padgett, J. ;
Guo, Y. .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
12345